Table 3 Sensitivity and specificity of the ensemble model at all thresholds, by different covariates.

From: Hybrid deep learning models for the screening of Diabetic Macular Edema in optical coherence tomography volumes

 

NDME (%)

Threshold 1

Threshold 2

Threshold 3

Sensitivity (95% CI)

Specificity (95% CI)

Sensitivity (95% CI)

Specificity (95% CI)

Sensitivity (95% CI)

Specificity 95% CI)

Gender

 Males

85 (67.5)

89.4 (80.9–95.0)

93.4 (92.5–94.3)

94.1 (86.8–98.1)

84.4 (83.1–85.7)

78.8 (68.6–86.9)

97.0 (96.3–97.5)

 Females

41 (32.5)

87.8 (73.8–95.9)

93.2 (92.1–94.3)

87.8 (73.8–95.9)

81.3 (79.5–82.9)

85.4 (70.8–94.4)

97.0 (96.2–97.7)

Age

  ≤ 65

56 (44.4)

94.6 (85.1–98.9)

95.8 (95.0–96.5)

94.6 (85.1–98.9)

88.4 (87.1–89.6)

91.1 (80.4–97.0)

98.0 (97.4–98.5)

  > 65

70 (55.6)

84.3 (73.6–91.9)

90.7 (89.6–91.8)

90.0 (80.5–95.9)

77.5 (75.8–79.1)

73.0 (61.4–82.6)

96.0 (95.2–96.7)

Laterality

 Left eye

61 (48.4)

89.2 (79.1–95.6)

94.2 (93.3–95.1)

90.8 (81.0–96.5)

85.5 (84.1–86.8)

78.5 (66.5–87.7)

97.1 (96.3–97.7)

 Right eye

65 (51.6)

88.5 (77.8–95.3)

92.4 (91.3–93.4)

93.4 (84.1–98.2)

80.7 (79.1–82.2)

83.6 (71.9–91.8)

96.9 (96.2–97.6)

 BCVA, Snellen decimal:

  ≤ 0.5

46 (36.5)

95.7 (85.2–99.5)

81.8 (78.9–84.4)

97.8 (88.5–99.9)

63.4 (60.0–66.8)

82.6 (68.6–92.2)

91.5 (89.4–93.4)

  > 0.5

76 (63.5)

84.2 (74.0–91.6)

95.5 (94.8–96.1)

88.2 (78.7–94.4)

86.9 (85.9–87.9)

80.3 (69.5–88.5)

98.0 (97.6–98.4)

Type of diabetes

 1

6 (4.76)

83.3 (35.9–99.6)

95.0 (92.6–96.9)

83.3 (35.9–99.6)

88.7 (85.4–91.5)

33.3 (4.33–77.7)

97.3 (95.3–98.6)

 2

120 (95.2)

89.2 (82.2–94.1)

93.2 (92.4–93.9)

92.5 (86.2–96.5)

82.6 (81.5–83.7)

83.3 (75.4–89.5)

97.0 (96.5–97.5)

Duration of diabetes

  ≤ 15 years

67 (53.2)

95.5 (87.5–99.1)

94.7 (93.9–95.4)

97.0 (89.6–99.6)

84.6 (83.4–85.8)

85.1 (74.3–92.6)

97.8 (97.3–98.3)

  > 15 years

58 (46.8)

81.0 (68.6–90.1)

89.6 (87.9–91.1)

86.2 (74.6–93.9)

79.2 (76.9–81.3)

75.9 (62.8–86.1)

94.7 (93.4–95.8)

Grade of DME

 Mild

77 (61.1)

84.4 (74.4–91.7)

93.3 (92.6–94.0)

88.3 (79.0–94.5)

83.1 (82.1–84.1)

74.0 (62.8–83.4)

97.0 (96.5–97.4)

 Moderate and severe

46 (38.9)

97.8 (88.5–99.9)

93.3 (92.6–94.0)

100 (92.9–100)

83.1 (82.1–84.1)

93.5 (82.1–98.6)

97.0 (96.5–97.4)

Diabetic retinopathy

 Non-ST

97 (77.0)

86.6 (78.2–92.7)

93.7 (93.0–94.4)

90.7 (83.1–95.7)

83.5 (82.5–84.5)

78.4 (68.8–86.1)

97.3 (96.8–97.7)

 ST-DR*

28 (23.0)

96.4 (81.7–99.9)

51.4 (34.0–68.6)

96.4 (81.7–99.9)

40.0 (23.9–57.9)

89.3 (71.8–97.7)

62.9 (44.9–78.5)

OCT quality of image (TopQ)

  ≤ 40

43 (34.1)

90.7 (77.9–97.4)

80.8 (78.2–83.2)

95.4 (84.2–99.4)

61.0 (57.8–64.1)

83.7 (69.3–93.2)

92.3 (90.4–93.9)

  > 40

83 (65.9)

88.0 (79.0–94.1)

96.2 (95.6–96.8)

90.4 (81.9–95.8)

88.3 (87.2–89.2)

79.5 (69.2–87.6)

98.1 (97.6–98.5)

  1. NDME: 126; Nnon-DME: 5188.
  2. DME diabetic macular edema, CI confidence interval, BCVA best corrected visual acuity, ST sight-threatening, OCT optical coherence tomography.
  3. *ST-DR included severe non-proliferative and proliferative DR.